Literature DB >> 12799059

A circulatory model for calculating non-steady-state glucose fluxes. Validation and comparison with compartmental models.

Andrea Mari1, L Stojanovska, J Proietto, A W Thorburn.   

Abstract

This study presents a circulatory model of glucose kinetics for application to non-steady-state conditions, examines its ability to predict glucose appearance rates from a simulated oral glucose load, and compares its performance with compartmental models. A glucose tracer bolus was injected intravenously in rats to determine parameters of the circulatory and two-compartment models. A simulated oral glucose tolerance test was performed in another group of rats by infusing intravenously labeled glucose at variable rates. A primed continuous intravenous infusion of a second tracer was given to determine glucose clearance. The circulatory model gave the best estimate of glucose appearance, closely followed by the two-compartment model and a modified Steele one-compartment model with a larger total glucose volume. The standard one-compartment model provided the worst estimate. The average relative errors on the rate of glucose appearance were: circulatory, 10%; two-compartment, 13%; modified one-compartment, 11%; standard one-compartment, 16%. Recovery of the infused glucose dose was 93+/-2, 94+/-2, 92+/-2 and 85+/-2%, respectively. These results show that the circulatory model is an appropriate model for assessing glucose turnover during an oral glucose load.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12799059     DOI: 10.1016/s0169-2607(02)00097-4

Source DB:  PubMed          Journal:  Comput Methods Programs Biomed        ISSN: 0169-2607            Impact factor:   5.428


  21 in total

1.  Molecular characterization of insulin-mediated suppression of hepatic glucose production in vivo.

Authors:  Christopher J Ramnanan; Dale S Edgerton; Noelia Rivera; Jose Irimia-Dominguez; Ben Farmer; Doss W Neal; Margaret Lautz; E Patrick Donahue; Catalina M Meyer; Peter J Roach; Alan D Cherrington
Journal:  Diabetes       Date:  2010-02-25       Impact factor: 9.461

2.  Targeting insulin to the liver corrects defects in glucose metabolism caused by peripheral insulin delivery.

Authors:  Dale S Edgerton; Melanie Scott; Ben Farmer; Phillip E Williams; Peter Madsen; Thomas Kjeldsen; Christian L Brand; Christian Fledelius; Erica Nishimura; Alan D Cherrington
Journal:  JCI Insight       Date:  2019-02-26

3.  Peripherally delivered hepatopreferential insulin analog insulin-406 mimics the hypoglycaemia-sparing effect of portal vein human insulin infusion in dogs.

Authors:  Justin M Gregory; Guillaume Kraft; Melanie F Scott; Doss W Neal; Ben Farmer; Marta S Smith; Jon R Hastings; Peter Madsen; Thomas B Kjeldsen; Susanne Hostrup; Christian L Brand; Christian Fledelius; Erica Nishimura; Alan D Cherrington
Journal:  Diabetes Obes Metab       Date:  2019-07-08       Impact factor: 6.577

4.  Brain insulin action augments hepatic glycogen synthesis without suppressing glucose production or gluconeogenesis in dogs.

Authors:  Christopher J Ramnanan; Viswanathan Saraswathi; Marta S Smith; E Patrick Donahue; Ben Farmer; Tiffany D Farmer; Doss Neal; Philip E Williams; Margaret Lautz; Andrea Mari; Alan D Cherrington; Dale S Edgerton
Journal:  J Clin Invest       Date:  2011-08-25       Impact factor: 14.808

5.  Estimates of insulin sensitivity from the intravenous-glucose-modified-clamp test depend on suppression of lipolysis in type 2 diabetes: a randomised controlled trial.

Authors:  Sabine Kahl; Bettina Nowotny; Simon Piepel; Peter J Nowotny; Klaus Strassburger; Christian Herder; Giovanni Pacini; Michael Roden
Journal:  Diabetologia       Date:  2014-07-22       Impact factor: 10.122

6.  Roux-en-Y gastric bypass compared with equivalent diet restriction: Mechanistic insights into diabetes remission.

Authors:  Laurentiu M Pop; Andrea Mari; Tong-Jin Zhao; Lori Mitchell; Shawn Burgess; Xilong Li; Beverley Adams-Huet; Ildiko Lingvay
Journal:  Diabetes Obes Metab       Date:  2018-04-10       Impact factor: 6.577

7.  Glucose autoregulation is the dominant component of the hormone-independent counterregulatory response to hypoglycemia in the conscious dog.

Authors:  Justin M Gregory; Noelia Rivera; Guillaume Kraft; Jason J Winnick; Ben Farmer; Eric J Allen; E Patrick Donahue; Marta S Smith; Dale S Edgerton; Phillip E Williams; Alan D Cherrington
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-05-16       Impact factor: 4.310

8.  Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients.

Authors:  Ele Ferrannini; Elza Muscelli; Silvia Frascerra; Simona Baldi; Andrea Mari; Tim Heise; Uli C Broedl; Hans-Juergen Woerle
Journal:  J Clin Invest       Date:  2014-01-27       Impact factor: 14.808

9.  Mechanisms through which a small protein and lipid preload improves glucose tolerance.

Authors:  Domenico Tricò; Simona Baldi; Alberto Tulipani; Silvia Frascerra; Maria Paula Macedo; Andrea Mari; Ele Ferrannini; Andrea Natali
Journal:  Diabetologia       Date:  2015-07-30       Impact factor: 10.122

10.  Effects of 11β-hydroxysteroid dehydrogenase-1 inhibition on hepatic glycogenolysis and gluconeogenesis.

Authors:  J J Winnick; C J Ramnanan; V Saraswathi; J Roop; M Scott; P Jacobson; P Jung; R Basu; A D Cherrington; D S Edgerton
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-02-12       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.